Details

Robin Reschke (third from left), a physician in the Department of Dermatology at Heidelberg University Hospital and at the NCT Heidelberg, has achieved a double success for his Max Eder research group: He will personally receive one of the Else Kröner Memorial Scholarships for 2025, which are endowed with €250,000.

The memorial scholarship for outstanding young medical professionals will finance his position for two years to allow him sufficient protected research time and will also provide additional material resources. Robin Reschke was also successful with an initial application to the Else Kröner-Fresenius-Stiftung, which will provide his working group with an additional €300,000 in funding for material resources.

The funded project investigates immune-related adverse events (irAEs) in patients treated with immune checkpoint inhibitors (ICI) for skin cancer. These side effects can affect almost all organs and lead to the discontinuation of life-sustaining therapies. Until now, cortisone has mostly been used to treat the side effects. However, this weakens the immune system and can impair the positive effects of ICI therapy. The aim of the project is therefore to find new molecular targets in tissue samples and blood in order to enable better, personalized treatment approaches for irAEs, including across different types of cancer.

Further information on the Else Kröner Memorial Scholarship 2025